Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Parental-Report Questionnaire for Language Abilities and Pragmatics in Children and Adolescents with Autism Spectrum Disorders. | Brain Sci | 2023 | 36831739 | PubTator, text mining | PubMed |
| Clinical Scores, Biomarkers and IT Tools in Lung Cancer Screening-Can an Integrated Approach Overcome Current Challenges? | Cancers (Basel) | 2023 | 36831559 | PubTator, text mining | PubMed |
| Disentangling Crocus Series Verni and Its Polyploids. | Biology (Basel) | 2023 | 36829579 | PubTator, text mining | PubMed |
| Polysaccharide-Based Hydrogels and Their Application as Drug Delivery Systems in Cancer Treatment: A Review. | J Funct Biomater | 2023 | 36826854 | PubTator, text mining | PubMed |
| Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women. | Br J Cancer | 2023 | 36807337 | PubTator, text mining | PubMed |
| Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. | J Allergy Clin Immunol | 2023 | 36804595 | PubTator, text mining | PubMed |
| MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. | Cancer Cell Int | 2023 | 36803831 | PubTator, text mining | PubMed |
| ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. | Proc Natl Acad Sci U S A | 2023 | 36791109 | PubTator, text mining | PubMed |
| Factors in oral-related quality of life of betel quid users receiving oral mucosal screening: a cross‑sectional study in Taiwan. | BMC Oral Health | 2023 | 36782200 | PubTator, text mining | PubMed |
| SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responses. | bioRxiv | 2023 | 36778224 | PubTator, text mining | PubMed |
| Classification of Skin Cancer Using Novel Hyperspectral Imaging Engineering via YOLOv5. | J Clin Med | 2023 | 36769781 | PubTator, text mining | PubMed |
| Short-Term Treatment with Rho-Associated Kinase Inhibitor Preserves Keratinocyte Stem Cell Characteristics In Vitro. | Cells | 2023 | 36766688 | PubTator, text mining | PubMed |
| Cellular angiofibroma in the retroperitoneal space during pregnancy: A case report. | BMC Womens Health | 2023 | 36765343 | PubTator, text mining | PubMed |
| Superenhancers as master gene regulators and novel therapeutic targets in brain tumors. | Exp Mol Med | 2023 | 36720920 | PubTator, text mining | PubMed |
| Lipid biomarkers that reflect postoperative recurrence risk in lung cancer patients who smoke: a case-control study. | Lipids Health Dis | 2023 | 36707819 | PubTator, text mining | PubMed |
| DNA Methylation Analysis of the SHOX2 and RASSF1A Panel Using Cell-Free DNA in the Diagnosis of Malignant Pleural Effusion. | J Oncol | 2023 | 36691467 | PubTator, text mining | PubMed |
| Differential Serum Proteomic Signatures between Acute Aortic Dissection and Acute Myocardial Infarction. | Biomedicines | 2023 | 36672669 | PubTator, text mining | PubMed |
| Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature. | Curr Oncol | 2023 | 36661732 | PubTator, text mining | PubMed |
| Human lung carcinomas synthesize immunoregulatory glucocorticoids. | Genes Immun | 2023 | 36653475 | PubTator, text mining | PubMed |
| A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer. | Ann Gastroenterol Surg | 2023 | 36643362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=17